Cure of Helicobacter pylori-positive active duodenal ulcer patients: A double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy

F. Di Mario, A. Caroli, V. Marcon, G. Ronzani, G. Battaglia, F. Costan-Biedo, R. Marin, A. Saggioro, N. Dal Bò, R. De Bastiani, F. Monica, G. Tafner, G. Leandro, B. Germanà, P. Olivieri, E. Benedetti, S. Andrea Grassi, N. Orzes, E. Bottona, D. MadiaA. Pilotto

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Aims. To compare a two-week dual therapy to a one-week triple therapy for the healing of duodenal ulcer and the eradication of the Helicobacter pylori infection. Patients and Methods. A total of 165 patients with active duodenal ulcer were enrolled in the study. At entry, endoscopy, clinical examination and laboratory tests were performed. Histology and the rapid urease test were used to diagnose Helicobacter pylori infection. Patients received either lansoprazole 30 mg plus amoxycillin 1 g bid for two weeks (two-week, dual therapy) or lansoprazole 30 mg plus amoxycillin 1 g plus tinidazole 500 mg bid for one week plus lansoprazole qd for an additional week (one-week, triple therapy). Two and twelve months after cessation of therapy, endoscopy and clinical assessments were repeated. Results. Duodenal ulcer healing and Helicobacter pylori eradication were both significantly greater (p

Original languageEnglish
Pages (from-to)108-115
Number of pages8
JournalDigestive and Liver Disease
Volume32
Issue number2
Publication statusPublished - Mar 2000

Fingerprint

Duodenal Ulcer
Helicobacter pylori
Lansoprazole
Amoxicillin
Helicobacter Infections
Endoscopy
Tinidazole
Therapeutics
Urease
Histology

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Cure of Helicobacter pylori-positive active duodenal ulcer patients : A double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. / Di Mario, F.; Caroli, A.; Marcon, V.; Ronzani, G.; Battaglia, G.; Costan-Biedo, F.; Marin, R.; Saggioro, A.; Dal Bò, N.; De Bastiani, R.; Monica, F.; Tafner, G.; Leandro, G.; Germanà, B.; Olivieri, P.; Benedetti, E.; Andrea Grassi, S.; Orzes, N.; Bottona, E.; Madia, D.; Pilotto, A.

In: Digestive and Liver Disease, Vol. 32, No. 2, 03.2000, p. 108-115.

Research output: Contribution to journalArticle

Di Mario, F, Caroli, A, Marcon, V, Ronzani, G, Battaglia, G, Costan-Biedo, F, Marin, R, Saggioro, A, Dal Bò, N, De Bastiani, R, Monica, F, Tafner, G, Leandro, G, Germanà, B, Olivieri, P, Benedetti, E, Andrea Grassi, S, Orzes, N, Bottona, E, Madia, D & Pilotto, A 2000, 'Cure of Helicobacter pylori-positive active duodenal ulcer patients: A double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy', Digestive and Liver Disease, vol. 32, no. 2, pp. 108-115.
Di Mario, F. ; Caroli, A. ; Marcon, V. ; Ronzani, G. ; Battaglia, G. ; Costan-Biedo, F. ; Marin, R. ; Saggioro, A. ; Dal Bò, N. ; De Bastiani, R. ; Monica, F. ; Tafner, G. ; Leandro, G. ; Germanà, B. ; Olivieri, P. ; Benedetti, E. ; Andrea Grassi, S. ; Orzes, N. ; Bottona, E. ; Madia, D. ; Pilotto, A. / Cure of Helicobacter pylori-positive active duodenal ulcer patients : A double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. In: Digestive and Liver Disease. 2000 ; Vol. 32, No. 2. pp. 108-115.
@article{7771daed74284f5697126ebbd6cb588c,
title = "Cure of Helicobacter pylori-positive active duodenal ulcer patients: A double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy",
abstract = "Aims. To compare a two-week dual therapy to a one-week triple therapy for the healing of duodenal ulcer and the eradication of the Helicobacter pylori infection. Patients and Methods. A total of 165 patients with active duodenal ulcer were enrolled in the study. At entry, endoscopy, clinical examination and laboratory tests were performed. Histology and the rapid urease test were used to diagnose Helicobacter pylori infection. Patients received either lansoprazole 30 mg plus amoxycillin 1 g bid for two weeks (two-week, dual therapy) or lansoprazole 30 mg plus amoxycillin 1 g plus tinidazole 500 mg bid for one week plus lansoprazole qd for an additional week (one-week, triple therapy). Two and twelve months after cessation of therapy, endoscopy and clinical assessments were repeated. Results. Duodenal ulcer healing and Helicobacter pylori eradication were both significantly greater (p",
author = "{Di Mario}, F. and A. Caroli and V. Marcon and G. Ronzani and G. Battaglia and F. Costan-Biedo and R. Marin and A. Saggioro and {Dal B{\`o}}, N. and {De Bastiani}, R. and F. Monica and G. Tafner and G. Leandro and B. German{\`a} and P. Olivieri and E. Benedetti and {Andrea Grassi}, S. and N. Orzes and E. Bottona and D. Madia and A. Pilotto",
year = "2000",
month = "3",
language = "English",
volume = "32",
pages = "108--115",
journal = "Digestive and Liver Disease",
issn = "1590-8658",
publisher = "Elsevier B.V.",
number = "2",

}

TY - JOUR

T1 - Cure of Helicobacter pylori-positive active duodenal ulcer patients

T2 - A double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy

AU - Di Mario, F.

AU - Caroli, A.

AU - Marcon, V.

AU - Ronzani, G.

AU - Battaglia, G.

AU - Costan-Biedo, F.

AU - Marin, R.

AU - Saggioro, A.

AU - Dal Bò, N.

AU - De Bastiani, R.

AU - Monica, F.

AU - Tafner, G.

AU - Leandro, G.

AU - Germanà, B.

AU - Olivieri, P.

AU - Benedetti, E.

AU - Andrea Grassi, S.

AU - Orzes, N.

AU - Bottona, E.

AU - Madia, D.

AU - Pilotto, A.

PY - 2000/3

Y1 - 2000/3

N2 - Aims. To compare a two-week dual therapy to a one-week triple therapy for the healing of duodenal ulcer and the eradication of the Helicobacter pylori infection. Patients and Methods. A total of 165 patients with active duodenal ulcer were enrolled in the study. At entry, endoscopy, clinical examination and laboratory tests were performed. Histology and the rapid urease test were used to diagnose Helicobacter pylori infection. Patients received either lansoprazole 30 mg plus amoxycillin 1 g bid for two weeks (two-week, dual therapy) or lansoprazole 30 mg plus amoxycillin 1 g plus tinidazole 500 mg bid for one week plus lansoprazole qd for an additional week (one-week, triple therapy). Two and twelve months after cessation of therapy, endoscopy and clinical assessments were repeated. Results. Duodenal ulcer healing and Helicobacter pylori eradication were both significantly greater (p

AB - Aims. To compare a two-week dual therapy to a one-week triple therapy for the healing of duodenal ulcer and the eradication of the Helicobacter pylori infection. Patients and Methods. A total of 165 patients with active duodenal ulcer were enrolled in the study. At entry, endoscopy, clinical examination and laboratory tests were performed. Histology and the rapid urease test were used to diagnose Helicobacter pylori infection. Patients received either lansoprazole 30 mg plus amoxycillin 1 g bid for two weeks (two-week, dual therapy) or lansoprazole 30 mg plus amoxycillin 1 g plus tinidazole 500 mg bid for one week plus lansoprazole qd for an additional week (one-week, triple therapy). Two and twelve months after cessation of therapy, endoscopy and clinical assessments were repeated. Results. Duodenal ulcer healing and Helicobacter pylori eradication were both significantly greater (p

UR - http://www.scopus.com/inward/record.url?scp=12944250857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=12944250857&partnerID=8YFLogxK

M3 - Article

C2 - 10975783

AN - SCOPUS:12944250857

VL - 32

SP - 108

EP - 115

JO - Digestive and Liver Disease

JF - Digestive and Liver Disease

SN - 1590-8658

IS - 2

ER -